Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
PROTEOMICS – Clinical Applications · 2022-11 · 16 (6)
DOI: 10.1002/prca.202100097 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PROTEOMICS – Clinical Applications, online erschienen am 11.05.2022. Verfasst von Bo He und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichu…. Hauptthemen laut MEDLINE: Proteomics, COVID-19. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 300 Literaturangaben.
Abstract (Originalsprache)
In the context of precision medicine, disease treatment requires individualized strategies based on the underlying molecular characteristics to overcome therapeutic challenges posed by heterogeneity. For this purpose, it is essential to develop new biomarkers to diagnose, stratify, or possibly prevent diseases. Plasma is an available source of biomarkers that greatly reflects the physiological and pathological conditions of the body. An increasing number of studies are focusing on proteins and peptides, including many involving the Human Proteome Project (HPP) of the Human Proteome Organization (HUPO), and proteomics and peptidomics techniques are emerging as critical tools for developing novel precision medicine preventative measures. Excitingly, the emerging plasma proteomics and peptidomics toolbox exhibits a huge potential for studying pathogenesis of diseases (e.g., COVID‐19 and cancer), identifying valuable biomarkers and improving clinical management. However, the enormous complexity and wide dynamic range of plasma proteins makes plasma proteome profiling challenging. Herein, we summarize the recent advances in plasma proteomics and peptidomics with a focus on their emerging roles in COVID‐19 and cancer research, aiming to emphasize the significance of plasma proteomics and peptidomics in clinical applications and precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University and Collaborative Innovation Center for Biotherapy, Chen…
- Department of Pharmacology, and Provincial Key Laboratory of Pathophysiology in Ningbo University School of Medicine, Ningbo, Zhejiang, China.
- Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
ORCID-Profile: Canhua Huang
Zitieren
APA
He, B., Huang, Z., Huang, C., & Nice, E. C. (2022). Clinical applications of plasma proteomics and peptidomics: Towards precision medicine. PROTEOMICS – Clinical Applications, 16(6). https://doi.org/10.1002/prca.202100097
Vancouver
He B, Huang Z, Huang C, Nice EC. Clinical applications of plasma proteomics and peptidomics: Towards precision medicine. PROTEOMICS – Clinical Applications. 2022;16(6). doi:10.1002/prca.202100097
BibTeX
@article{He2022,
author = {He, Bo and Huang, Zhao and Huang, Canhua and Nice, Edouard C},
title = {Clinical applications of plasma proteomics and peptidomics: Towards precision medicine},
journal = {PROTEOMICS – Clinical Applications},
year = {2022},
volume = {16},
number = {6},
doi = {10.1002/prca.202100097}
}
EUVIMED